Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Forte Biosciences, Inc. (FBRX) had Income from Continuous Operations of $-69.38M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-69.38M |
|
-- |
|
-- |
|
$70.66M |
|
$-70.66M |
|
$2.32M |
|
$-68.34M |
|
$-68.34M |
|
$-69.38M |
|
|
Income from Continuous Operations |
$-69.38M |
$-69.38M |
|
$-69.38M |
|
$-70.66M |
|
$-70.83M |
|
14.72M |
|
14.72M |
|
$-4.71 |
|
$-4.71 |
|
| Balance Sheet Financials | |
$80.59M |
|
$0.13M |
|
$2.19M |
|
$82.78M |
|
$20.75M |
|
-- |
|
$1.04M |
|
$21.79M |
|
$60.99M |
|
$60.99M |
|
$60.99M |
|
12.95M |
|
| Cash Flow Statement Financials | |
$-50.88M |
|
$36.23M |
|
$69.36M |
|
$22.24M |
|
$76.96M |
|
$54.71M |
|
$6.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-113.75% |
|
-113.75% |
|
-83.81% |
|
-113.75% |
|
$4.71 |
|
$-3.47 |
|
$-3.46 |
|